Danny van der Duin

Danny van der Duin has a diverse work experience that spans various industries. Danny currently works at Norgine as the Launch Brand Lead Benelux, where they oversee the commercial budget and holds end-to-end responsibility for products in the area of Gynaecology. Danny also creates local cross-functional strategies, executes brand plans, and collaborates with the global team. Prior to this, they were a Product Manager Netherlands at Norgine and a Medical Representative.

Before joining Norgine, Danny worked at Centrient Pharmaceuticals, where they held roles such as Global Business Manager Drug Products and Marketing Coordinator Drug Products. Danny was responsible for developing and executing strategic business plans for the company's portfolio. Danny also worked as a Trainee Marketing Manager Drug Products.

Danny's earlier work experience includes a research project at the DKFZ German Cancer Research Center, where they conducted (Epi)genetical Characterization of Acinar Cell Carcinoma. Danny also worked on a research project in Neuroscience/Human Genetics at Leiden University Medical Center and served as a Lab Assistant at the Department of Human Genetics.

In addition, Danny had a research internship in Endocrinology/Epidemiology at Erasmus MC, where they investigated the association of advanced glycation end products with various diseases. Danny also worked as a Student Assistant at Erasmus CMDz and held multiple roles at Thuiszorg Rotterdam, including Medewerker Ketenzorg and Stagiair Kwaliteit & Projecten.

Danny's earliest work experience was as a Student Assistant at iBMG.

Danny van der Duin earned a Bachelor of Science (BSc) degree in Health/Health Care Administration/Management from Erasmus University Rotterdam in 2014. Danny then pursued a Bachelor of Science (BSc) degree in Biomedical Sciences, General at Leiden University from 2012 to 2015. Following that, they completed a Master of Science (MSc) degree in Biomedical Sciences, General at Leiden University from 2015 to 2017. In 2016, they briefly studied Major Cancer Biology at Heidelberg University. Danny also obtained a VWO degree in Natuur & Techniek from Sint Laurens college in 2008. In terms of additional certifications, they completed a course on "Strategy and Planning for Commercial Launch Success in Pharma" with Kurt Arco at CELforPharma in 2022.